Cover Image
Market Research Report
Product code 
1052163

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2028

Published: | QYResearch | 105 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2028
Published: January 20, 2022
QYResearch
Content info: 105 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.

Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market

Due to the COVID-19 pandemic, the global Gastrointestinal OTC Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Laxatives accounting for % of the Gastrointestinal OTC Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

China Gastrointestinal OTC Drugs market size is valued at US$ million in 2021, while the US and Europe Gastrointestinal OTC Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gastrointestinal OTC Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Gastrointestinal OTC Drugs Scope and Segment

Gastrointestinal OTC Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Laxatives
  • Anti-Flatulents
  • H2-Antaginists
  • Anti-Diarrheals
  • PPIs
  • Anti-Emetics
  • Other

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Company

  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Bayer
  • Procter & Gamble
  • Perrigo
  • Abbott
  • Sanofi
  • Teva Pharmaceutical
  • Nestle
  • Boehringer Ingelheim
  • Reckitt Benckiser
  • Purdue Pharma

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Gastrointestinal OTC Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Laxatives
    • 1.2.3 Anti-Flatulents
    • 1.2.4 H2-Antaginists
    • 1.2.5 Anti-Diarrheals
    • 1.2.6 PPIs
    • 1.2.7 Anti-Emetics
    • 1.2.8 Other
  • 1.3 Market by Application
    • 1.3.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Gastrointestinal OTC Drugs Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Gastrointestinal OTC Drugs Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Gastrointestinal OTC Drugs Sales by Region
    • 2.4.1 Global Gastrointestinal OTC Drugs Sales by Region (2017-2022)
    • 2.4.2 Global Sales Gastrointestinal OTC Drugs by Region (2023-2028)
  • 2.5 Global Gastrointestinal OTC Drugs Revenue by Region
    • 2.5.1 Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022)
    • 2.5.2 Global Gastrointestinal OTC Drugs Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers
    • 3.1.1 Global Top Gastrointestinal OTC Drugs Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrointestinal OTC Drugs in 2021
  • 3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturers
    • 3.2.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2021
  • 3.3 Global Gastrointestinal OTC Drugs Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Gastrointestinal OTC Drugs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Gastrointestinal OTC Drugs Sales by Type
    • 4.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Type (2017-2022)
    • 4.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • 4.2 Global Gastrointestinal OTC Drugs Revenue by Type
    • 4.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • 4.3 Global Gastrointestinal OTC Drugs Price by Type
    • 4.3.1 Global Gastrointestinal OTC Drugs Price by Type (2017-2022)
    • 4.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Gastrointestinal OTC Drugs Sales by Application
    • 5.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Application (2017-2022)
    • 5.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • 5.2 Global Gastrointestinal OTC Drugs Revenue by Application
    • 5.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • 5.3 Global Gastrointestinal OTC Drugs Price by Application
    • 5.3.1 Global Gastrointestinal OTC Drugs Price by Application (2017-2022)
    • 5.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Gastrointestinal OTC Drugs Market Size by Type
    • 6.1.1 North America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
    • 6.1.2 North America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
  • 6.2 North America Gastrointestinal OTC Drugs Market Size by Application
    • 6.2.1 North America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
    • 6.2.2 North America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
  • 6.3 North America Gastrointestinal OTC Drugs Market Size by Country
    • 6.3.1 North America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
    • 6.3.2 North America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Gastrointestinal OTC Drugs Market Size by Type
    • 7.1.1 Europe Gastrointestinal OTC Drugs Sales by Type (2017-2028)
    • 7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
  • 7.2 Europe Gastrointestinal OTC Drugs Market Size by Application
    • 7.2.1 Europe Gastrointestinal OTC Drugs Sales by Application (2017-2028)
    • 7.2.2 Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
  • 7.3 Europe Gastrointestinal OTC Drugs Market Size by Country
    • 7.3.1 Europe Gastrointestinal OTC Drugs Sales by Country (2017-2028)
    • 7.3.2 Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Gastrointestinal OTC Drugs Market Size by Type
    • 8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Application
    • 8.2.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
    • 8.3.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Gastrointestinal OTC Drugs Market Size by Type
    • 9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
    • 9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
  • 9.2 Latin America Gastrointestinal OTC Drugs Market Size by Application
    • 9.2.1 Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
    • 9.2.2 Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
  • 9.3 Latin America Gastrointestinal OTC Drugs Market Size by Country
    • 9.3.1 Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
    • 9.3.2 Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Type
    • 10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Application
    • 10.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country
    • 10.3.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Overview
    • 11.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 GlaxoSmithKline Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Overview
    • 11.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Pfizer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Overview
    • 11.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Johnson & Johnson Recent Developments
  • 11.4 Bayer
    • 11.4.1 Bayer Corporation Information
    • 11.4.2 Bayer Overview
    • 11.4.3 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Bayer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bayer Recent Developments
  • 11.5 Procter & Gamble
    • 11.5.1 Procter & Gamble Corporation Information
    • 11.5.2 Procter & Gamble Overview
    • 11.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Procter & Gamble Recent Developments
  • 11.6 Perrigo
    • 11.6.1 Perrigo Corporation Information
    • 11.6.2 Perrigo Overview
    • 11.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Perrigo Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Perrigo Recent Developments
  • 11.7 Abbott
    • 11.7.1 Abbott Corporation Information
    • 11.7.2 Abbott Overview
    • 11.7.3 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Abbott Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Abbott Recent Developments
  • 11.8 Sanofi
    • 11.8.1 Sanofi Corporation Information
    • 11.8.2 Sanofi Overview
    • 11.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Sanofi Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Sanofi Recent Developments
  • 11.9 Teva Pharmaceutical
    • 11.9.1 Teva Pharmaceutical Corporation Information
    • 11.9.2 Teva Pharmaceutical Overview
    • 11.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Teva Pharmaceutical Recent Developments
  • 11.10 Nestle
    • 11.10.1 Nestle Corporation Information
    • 11.10.2 Nestle Overview
    • 11.10.3 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Nestle Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Nestle Recent Developments
  • 11.11 Boehringer Ingelheim
    • 11.11.1 Boehringer Ingelheim Corporation Information
    • 11.11.2 Boehringer Ingelheim Overview
    • 11.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Boehringer Ingelheim Recent Developments
  • 11.12 Reckitt Benckiser
    • 11.12.1 Reckitt Benckiser Corporation Information
    • 11.12.2 Reckitt Benckiser Overview
    • 11.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Reckitt Benckiser Recent Developments
  • 11.13 Purdue Pharma
    • 11.13.1 Purdue Pharma Corporation Information
    • 11.13.2 Purdue Pharma Overview
    • 11.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Purdue Pharma Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Purdue Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Gastrointestinal OTC Drugs Industry Chain Analysis
  • 12.2 Gastrointestinal OTC Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Gastrointestinal OTC Drugs Production Mode & Process
  • 12.4 Gastrointestinal OTC Drugs Sales and Marketing
    • 12.4.1 Gastrointestinal OTC Drugs Sales Channels
    • 12.4.2 Gastrointestinal OTC Drugs Distributors
  • 12.5 Gastrointestinal OTC Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Gastrointestinal OTC Drugs Industry Trends
  • 13.2 Gastrointestinal OTC Drugs Market Drivers
  • 13.3 Gastrointestinal OTC Drugs Market Challenges
  • 13.4 Gastrointestinal OTC Drugs Market Restraints

14 Key Findings in The Global Gastrointestinal OTC Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Laxatives
  • Table 3. Major Manufacturers of Anti-Flatulents
  • Table 4. Major Manufacturers of H2-Antaginists
  • Table 5. Major Manufacturers of Anti-Diarrheals
  • Table 6. Major Manufacturers of PPIs
  • Table 7. Major Manufacturers of Anti-Emetics
  • Table 8. Major Manufacturers of Other
  • Table 9. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 10. Global Gastrointestinal OTC Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 11. Global Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
  • Table 12. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022)
  • Table 13. Global Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
  • Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2023-2028)
  • Table 15. Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 16. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022)
  • Table 17. Global Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2023-2028)
  • Table 19. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
  • Table 20. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2017-2022)
  • Table 21. Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 22. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2017-2022)
  • Table 23. Gastrointestinal OTC Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
  • Table 24. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2021)
  • Table 26. Gastrointestinal OTC Drugs Manufacturing Base Distribution and Headquarters
  • Table 27. Manufacturers Gastrointestinal OTC Drugs Product Offered
  • Table 28. Date of Manufacturers Enter into Gastrointestinal OTC Drugs Market
  • Table 29. Mergers & Acquisitions, Expansion Plans
  • Table 30. Global Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 31. Global Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 32. Global Gastrointestinal OTC Drugs Sales Share by Type (2017-2022)
  • Table 33. Global Gastrointestinal OTC Drugs Sales Share by Type (2023-2028)
  • Table 34. Global Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 35. Global Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 36. Global Gastrointestinal OTC Drugs Revenue Share by Type (2017-2022)
  • Table 37. Global Gastrointestinal OTC Drugs Revenue Share by Type (2023-2028)
  • Table 38. Gastrointestinal OTC Drugs Price by Type (2017-2022) & (USD/Pcs)
  • Table 39. Global Gastrointestinal OTC Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
  • Table 40. Global Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 41. Global Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 42. Global Gastrointestinal OTC Drugs Sales Share by Application (2017-2022)
  • Table 43. Global Gastrointestinal OTC Drugs Sales Share by Application (2023-2028)
  • Table 44. Global Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 45. Global Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 46. Global Gastrointestinal OTC Drugs Revenue Share by Application (2017-2022)
  • Table 47. Global Gastrointestinal OTC Drugs Revenue Share by Application (2023-2028)
  • Table 48. Gastrointestinal OTC Drugs Price by Application (2017-2022) & (USD/Pcs)
  • Table 49. Global Gastrointestinal OTC Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
  • Table 50. North America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 51. North America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 52. North America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 53. North America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 54. North America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 55. North America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 56. North America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 57. North America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 58. North America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 59. North America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 60. North America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 61. North America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 62. Europe Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 63. Europe Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 64. Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 65. Europe Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 66. Europe Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 67. Europe Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 68. Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 69. Europe Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 70. Europe Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 71. Europe Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 72. Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 73. Europe Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 75. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 76. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 79. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 80. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 82. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
  • Table 83. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
  • Table 84. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 85. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 86. Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 87. Latin America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 88. Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 89. Latin America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 90. Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 91. Latin America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 92. Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 93. Latin America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 94. Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 95. Latin America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 96. Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 97. Latin America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 99. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 100. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 103. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 104. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 106. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 107. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 108. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 109. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 110. GlaxoSmithKline Corporation Information
  • Table 111. GlaxoSmithKline Description and Major Businesses
  • Table 112. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 113. GlaxoSmithKline Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. GlaxoSmithKline Recent Developments
  • Table 115. Pfizer Corporation Information
  • Table 116. Pfizer Description and Major Businesses
  • Table 117. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 118. Pfizer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Pfizer Recent Developments
  • Table 120. Johnson & Johnson Corporation Information
  • Table 121. Johnson & Johnson Description and Major Businesses
  • Table 122. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 123. Johnson & Johnson Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Johnson & Johnson Recent Developments
  • Table 125. Bayer Corporation Information
  • Table 126. Bayer Description and Major Businesses
  • Table 127. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 128. Bayer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Bayer Recent Developments
  • Table 130. Procter & Gamble Corporation Information
  • Table 131. Procter & Gamble Description and Major Businesses
  • Table 132. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 133. Procter & Gamble Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Procter & Gamble Recent Developments
  • Table 135. Perrigo Corporation Information
  • Table 136. Perrigo Description and Major Businesses
  • Table 137. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 138. Perrigo Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Perrigo Recent Developments
  • Table 140. Abbott Corporation Information
  • Table 141. Abbott Description and Major Businesses
  • Table 142. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 143. Abbott Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Abbott Recent Developments
  • Table 145. Sanofi Corporation Information
  • Table 146. Sanofi Description and Major Businesses
  • Table 147. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 148. Sanofi Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Sanofi Recent Developments
  • Table 150. Teva Pharmaceutical Corporation Information
  • Table 151. Teva Pharmaceutical Description and Major Businesses
  • Table 152. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 153. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. Teva Pharmaceutical Recent Developments
  • Table 155. Nestle Corporation Information
  • Table 156. Nestle Description and Major Businesses
  • Table 157. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 158. Nestle Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Nestle Recent Developments
  • Table 160. Boehringer Ingelheim Corporation Information
  • Table 161. Boehringer Ingelheim Description and Major Businesses
  • Table 162. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 163. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Boehringer Ingelheim Recent Developments
  • Table 165. Reckitt Benckiser Corporation Information
  • Table 166. Reckitt Benckiser Description and Major Businesses
  • Table 167. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 168. Reckitt Benckiser Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 169. Reckitt Benckiser Recent Developments
  • Table 170. Purdue Pharma Corporation Information
  • Table 171. Purdue Pharma Description and Major Businesses
  • Table 172. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 173. Purdue Pharma Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 174. Purdue Pharma Recent Developments
  • Table 175. Key Raw Materials Lists
  • Table 176. Raw Materials Key Suppliers Lists
  • Table 177. Gastrointestinal OTC Drugs Distributors List
  • Table 178. Gastrointestinal OTC Drugs Customers List
  • Table 179. Gastrointestinal OTC Drugs Market Trends
  • Table 180. Gastrointestinal OTC Drugs Market Drivers
  • Table 181. Gastrointestinal OTC Drugs Market Challenges
  • Table 182. Gastrointestinal OTC Drugs Market Restraints
  • Table 183. Research Programs/Design for This Report
  • Table 184. Key Data Information from Secondary Sources
  • Table 185. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Gastrointestinal OTC Drugs Product Picture
  • Figure 3. Global Gastrointestinal OTC Drugs Market Share by Type in 2021 & 2028
  • Figure 3. Laxatives Product Picture
  • Figure 4. Anti-Flatulents Product Picture
  • Figure 5. H2-Antaginists Product Picture
  • Figure 6. Anti-Diarrheals Product Picture
  • Figure 7. PPIs Product Picture
  • Figure 8. Anti-Emetics Product Picture
  • Figure 9. Other Product Picture
  • Figure 10. Global Gastrointestinal OTC Drugs Market Share by Application in 2021 & 2028
  • Figure 11. Hospital Pharmacies
  • Figure 12. Retail Pharmacies
  • Figure 13. Online Pharmacies
  • Figure 14. Gastrointestinal OTC Drugs Report Years Considered
  • Figure 15. Global Gastrointestinal OTC Drugs Sales 2017-2028 (K Pcs)
  • Figure 16. Global Gastrointestinal OTC Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 17. Global Gastrointestinal OTC Drugs Revenue 2017-2028 (US$ Million)
  • Figure 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022)
  • Figure 20. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2023-2028)
  • Figure 21. North America Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 22. North America Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 24. Europe Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Asia-Pacific Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 26. Asia-Pacific Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. Latin America Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 28. Latin America Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. Middle East & Africa Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 30. Middle East & Africa Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 31. The Gastrointestinal OTC Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 32. The Top 5 and 10 Largest Manufacturers of Gastrointestinal OTC Drugs in the World: Market Share by Gastrointestinal OTC Drugs Revenue in 2021
  • Figure 33. Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 34. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 35. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 36. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 37. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 38. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 39. North America Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 40. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 41. North America Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 42. North America Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
  • Figure 43. North America Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
  • Figure 44. U.S. Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 45. Canada Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 46. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 47. Europe Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 48. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 49. Europe Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 50. Europe Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
  • Figure 51. Europe Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
  • Figure 52. Germany Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 53. France Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 54. U.K. Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 55. Italy Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 56. Russia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 57. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 58. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 59. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 60. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 61. Asia Pacific Gastrointestinal OTC Drugs Sales Share by Region (2017-2028)
  • Figure 62. Asia Pacific Gastrointestinal OTC Drugs Revenue Share by Region (2017-2028)
  • Figure 63. China Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 64. Japan Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 65. South Korea Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 66. India Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 67. Australia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 68. Taiwan Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 69. Indonesia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 70. Thailand Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 71. Malaysia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 72. Philippines Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 73. Latin America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 74. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 75. Latin America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 76. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 77. Latin America Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
  • Figure 78. Latin America Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
  • Figure 79. Mexico Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 80. Brazil Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 81. Argentina Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 82. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
  • Figure 83. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
  • Figure 84. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
  • Figure 85. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
  • Figure 86. Middle East and Africa Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
  • Figure 87. Middle East and Africa Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
  • Figure 88. Turkey Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 89. Saudi Arabia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 90. UAE Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 91. Gastrointestinal OTC Drugs Value Chain
  • Figure 92. Gastrointestinal OTC Drugs Production Process
  • Figure 93. Channels of Distribution
  • Figure 94. Distributors Profiles
  • Figure 95. Bottom-up and Top-down Approaches for This Report
  • Figure 96. Data Triangulation
  • Figure 97. Key Executives Interviewed